How does hospitalization affect continuity of drug therapy: an exploratory study

Por Blozik, Eva, Signorell, Andri, Reich, Oliver
Publicado no Ther Clin Risk Manag (2016)

Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosis

Por Doessegger, Lucette, Schmitt, Georg, Lenz, Barbara, Fischer, Holger, Schlotterbeck, Götz, Atzpodien, Elke-Astrid, Senn, Hans, Suter, Laura, Csato, Miklos, Evers, Stefan, Singer, Thomas
Publicado em 2013

Cardioprotection with halogenated gases: how does it occur?

Por Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose
Publicado no Drug Des Devel Ther (2017)

Low-dose metronomic oral dosing of a prodrug of Gemcitabine (LY2334737) causes anti-tumor effects in the absence of inhibition of systemic vasculogenesis

Por Francia, Giulio, Shaked, Yuval, Hashimoto, Kae, Sun, John, Yin, Melissa, Cesta, Carolyn, Xu, Ping, Man, Shan, Hackl, Christina, Stewart, Julie, Uhlik, Mark, Dantzig, Anne H., Foster, Stuart, Kerbel, Robert S.
Publicado em 2011

Paliperidone extended-release: does it have a place in antipsychotic therapy?

Por Gahr, Maximilian, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Lepping, Peter, Freudenmann, Roland W
Publicado em 2011

Magnesium: does it reduce ischemia/reperfusion injury in an adnexal torsion rat model?

Por Celik Kavak, Ebru, Gulcu Bulmus, Funda, Bulmus, Ozgur, Kavak, Salih Burcin, Kocaman, Nevin
Publicado no Drug Des Devel Ther (2018)

MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216

Por Reijers, Joannes A. A., Kallend, D. G., Malone, K. E., Jukema, J. W., Wijngaard, P. L. J., Burggraaf, J., Moerland, M.
Publicado no Cardiovasc Drugs Ther (2017)

Etoposide Sensitivity Does Not Predict MLL Rearrangements or Risk of Therapy-related Acute Myeloid Leukemia

Por Yang, Jun, Bogni, Alessia, Cheng, Cheng, Bleibel, Wasim K., Cai, Xiangjun, Fan, Yiping, Yang, Wenjian, Rocha, Jose Claudio C., Pei, Deqing, Liu, Wei, Dolan, M. Eileen, Pui, Ching-Hon, Relling, Mary V.
Publicado em 2008

Does remifentanil attenuate renal ischemia–reperfusion injury better than dexmedetomidine in rat kidney?

Por Erkılıç, E, Kesimci, E, Alaybeyoğlu, F, Kılınç, I, Tural, R, Yazgan, A, Gümüş, T, Sepici Dinçel, A, Dumlu, EG, Kanbak, O
Publicado no Drug Des Devel Ther (2017)

A review of studies of adherence with antihypertensive drugs using prescription databases

Por Fitz-Simon, Nicola, Bennett, Kathleen, Feely, John
Publicado em 2005

Dimethoxy-etomidate: A Nonhypnotic Etomidate Analog that Potently Inhibits Steroidogenesis

Por McGrath, Megan, Ma, Celena, Raines, Douglas E.
Publicado no J Pharmacol Exp Ther (2018)

Acetazolamide serves as selective delivery vehicle for dipeptide-linked drugs to renal cell carcinoma

Por Cazzamalli, Samuele, Dal Corso, Alberto, Neri, Dario
Publicado no Mol Cancer Ther (2016)

Glucose-Insulin Therapy, Plasma Substrate Levels and Cardiac Recovery After Cardiac Ischemic Events

Por Zuurbier, C. J., Van Wezel, H. B.
Publicado em 2008

A Small Molecule with Anticancer and Antimetastatic Activities Induces Rapid Mitochondrial-Associated Necrosis in Breast Cancer

Por Bastian, Anja, Thorpe, Jessica E., Disch, Bryan C., Bailey-Downs, Lora C., Gangjee, Aleem, Devambatla, Ravi K. V., Henthorn, Jim, Humphries, Kenneth M., Vadvalkar, Shraddha S., Ihnat, Michael A.
Publicado no J Pharmacol Exp Ther (2015)

Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana

Por Shapiro, Roger L, Rossi, Steven, Ogwu, Anthony, Moss, Mary, Leidner, Jean, Moffat, Claire, Lockman, Shahin, Moyo, Sikhulile, Makhema, Joseph, Essex, Max, Capparelli, Edmund
Publicado no Antivir Ther (2012)

Effect of low glycemic index food and postprandial exercise on blood glucose level, oxidative stress and antioxidant capacity

Por KASUYA, NORIAKI, OHTA, SHOICHIRO, TAKANAMI, YOSHIKAZU, KAWAI, YUKARI, INOUE, YUTAKA, MURATA, ISAMU, KANAMOTO, IKUO
Publicado no Exp Ther Med (2015)

Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review

Por Yu, Qiaowen, Guo, Qisen, Chen, Liangan, Liu, Shuwei
Publicado no Drug Des Devel Ther (2015)

Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’

Por Ptaszynska, Agata, Cohen, Samuel M., Messing, Edward M., Reilly, Timothy P., Johnsson, Eva, Johnsson, Kristina
Publicado no Diabetes Ther (2015)

The novel Bcl-2 inhibitor ABT-737 is more effective in hypoxia, and is able to reverse hypoxia-induced drug resistance in neuroblastoma cells

Por Klymenko, Tetyana, Brandenburg, Martin, Morrow, Christopher, Dive, Caroline, Makin, Guy
Publicado em 2011

A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma

Por Hu, Fei, Miao, Lin, Zhao, Yu, Xiao, Yuan-Yuan, Xu, Qing
Publicado no Drug Des Devel Ther (2015)